June 18, 2020 | 09:00
With SK Group recently joining the mergers and acquisitions race, Vietnam’s pharma and healthcare market is becoming more robust. However, newcomers are expected to face challenges amid increasingly mounting competition in the lucrative pharmaceutical market in the months to come, driven by the enforcement of the EU-Vietnam Free Trade Agreement.